• 13Mar

    EUPATI launches training course in medicines research for patients and advocates

    EUPATI (European Patients Academy on Therapeutic Innovation) have launched an expert training course for patients and patient representatives. It will offer advocates expert level training in medicines research and development, tailored to the individual participant.

    The programme is open to patient group staff or volunteers, patients with a chronic or lifelong condition, and carers or family members. It aims to encourage participants to apply the knowledge and skills acquired via three main areas:

    Patient Representation: EUPATI Patient Experts could actively engage in representing a patient perspective in the medicines development process by interacting with scientific committees, HTA agencies, industry, regulatory bodies, academia and other relevant stakeholders.

    Communication: EUPATI Patient Experts could contribute to raising awareness on patient involvement in medicines R&D amongst lay patients, hard-to-reach patients and the lay public. Some examples of activities: writing articles and press releases; organising press conferences; facilitating cooperation with media; being a spokesperson in TV and radio programmes; utilising social networks and blogs.

    Education/Training: EUPATI Patient Experts could play the role of facilitators/trainers by engaging in activities supporting the dissemination of the education and information programmes for patient advocates, lay patients and the general public in their countries, through their patient communities and networks. Some examples of activities: providing training to patient advocates; leading workshops; running information sessions for people interested in participating in clinical trials or wanting to learn more.

    The programme will cover the following six education modules:

    • Discovery of Medicines & Planning of Medicines Development
    • Non-Clinical Testing and Pharmaceutical Development
    • Exploratory and Confirmatory Clinical Development
    • Clinical Trials
    • Regulatory Affairs, Medicinal Product Safety, Pharmacovigilance and Pharmacoepidemiology
    • HTA principles and practices

    The programme consists of e-learning modules and two face-to-face training sessions. All successful candidates will receive a full scholarship to attend the training course. Travel, accommodation and food expenses for the face-to-face training sessions will be paid for by EUPATI.

    Full details including how to apply can be found here. The deadline for application is 20 April 2014.

    EUPATI is a consortium that exists to provide scientifically reliable, objective, comprehensive information to patients on the research and development process of medicines. It aims to increase the capacity of patients and the lay public to be effective advocates and advisors, eg, in clinical trials, with regulatory authorities and in ethics committees.